Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Nov 1;154(5):1618–1635. doi: 10.1084/jem.154.5.1618

Activated human monocytes inhibit the intracellular multiplication of legionnaires’ disease bacteria

MA Horwitz, SC Silverstein
PMCID: PMC2186504  PMID: 7299350

Abstract

We have examined the interaction between virulent egg yolk-grown L. pneumophila, Philadelphia 1 strain, and in vitro-activated human monocytes, under antibiotic-free conditions. Freshly explanted human monocytes activated by incubation with concanavalin A (Con A) and human lymphocytes inhibited the intracellular multiplication of L. pneumophila. Both Con A and lymphocytes were required for activation. Con A was consistently maximally effective at greater than or equal to 4 μg/ml. Monocytes activated by incubation with cell-free filtered supernatant from Con A-sensitized mononuclear cell cultures also inhibited the intracellular multiplication of L. pneumophil a. The most potent supernatant was obtained from mononuclear cell cultures incubated with greater than or equal to 15 μg/ml Con A for 48 h. The degree of monocyte inhibition of L. pneumophila multiplication was proportional to the length of time monocytes were preincubated with supernatant (48 {greater than} 24 {greater than} 12 h) and to the concentration of supernatant added (40 percent {greater than} 20 percent {greater than} 10 percent {greater than} 5 percent). Monocytes treated with supernatant daily were more inhibitory than monocytes treated initially only. With time in culture, monocytes progressively lost a limited degree of spontaneous inhibitory capacity and also lost their capacity to respond to supernatant with inhibition of L. pneumophila multiplication. Supernatant-activated monocytes inhibited L. pneumophila multiplication in two ways. They phagocytosed fewer bacteria, and they slowed the rate of intracellular multiplication of bacteria that were internalized. As was the case with nonactivated monocytes, antibody had no effect on the rate of intracellular multiplication in supernatant-activated monocytes. Neither supernatant-activated nor nonactivated monocytes killed L. pneumophila in the absence of antibody. Both killed a limited proportion of these bacteria in the presence of antibody and complement. We have previously reported that anti-L, pneumophila antibody and complement neither promote effective killing of L. pneumophila by human polymorphonuclear leukocytes and monocytes nor inhibit the rate of L. pneumophila multiplication in monocytes. These findings and our present report that activated monocytes do inhibit L. pneumophila multiplication indicate that cell-mediated immunity plays a major role in host defense against Legionnaires’ disease.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Ibrahim M. S., Valentine F. T., Lawrence H. S. Activated lymphocytes depress phagocytosis of latex particles by human monocyte-macrophages. Cell Immunol. 1978 Dec;41(2):217–230. doi: 10.1016/0008-8749(78)90220-4. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. E., Bautista S., Remington J. S. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J Immunol. 1976 Aug;117(2):381–387. [PubMed] [Google Scholar]
  3. Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bainton D. R., Golde D. W. Differentiation of macrophages from normal human bone marrow in liquid culture. Electron microscopy and cytochemistry. J Clin Invest. 1978 Jun;61(6):1555–1569. doi: 10.1172/JCI109076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bock B. V., Kirby B. D., Edelstein P. H., George W. L., Snyder K. M., Owens M. L., Hatayama C. M., Haley C. E., Lewis R. P., Meyer R. D. Legionnaires' disease in renal-transplant recipients. Lancet. 1978 Feb 25;1(8061):410–413. doi: 10.1016/s0140-6736(78)91202-3. [DOI] [PubMed] [Google Scholar]
  6. Borges J. S., Johnson W. D., Jr Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products. J Exp Med. 1975 Feb 1;141(2):483–496. doi: 10.1084/jem.141.2.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buchmüller Y., Mauel J. Studies on the mechanisms of macrophage activation. II. Parasite destruction in macrophages activated by supernates from concanavalin A-stimulated lymphocytes. J Exp Med. 1979 Aug 1;150(2):359–370. doi: 10.1084/jem.150.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cahall D. L., Youmans G. P. Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis. Infect Immun. 1975 Oct;12(4):833–840. doi: 10.1128/iai.12.4.833-840.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cole P. Activation of mouse peritoneal cells to kill Listeria monocytogenes by T-lymphocyte products. Infect Immun. 1975 Jul;12(1):36–41. doi: 10.1128/iai.12.1.36-41.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fowles R. E., Fajardo I. M., Leibowitch J. L., David J. R. The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med. 1973 Oct 1;138(4):952–964. doi: 10.1084/jem.138.4.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gump D. W., Frank R. O., Winn W. C., Jr, Foster R. S., Jr, Broome C. V., Cherry W. B. Legionnaires' disease in patients with associated serious disease. Ann Intern Med. 1979 Apr;90(4):538–542. doi: 10.7326/0003-4819-90-4-538. [DOI] [PubMed] [Google Scholar]
  12. Hoff R. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo. J Exp Med. 1975 Aug 1;142(2):299–311. doi: 10.1084/jem.142.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Horwitz M. A., Silverstein S. C. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest. 1980 Jan;65(1):82–94. doi: 10.1172/JCI109663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Horwitz M. A., Silverstein S. C. Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med. 1981 Feb 1;153(2):386–397. doi: 10.1084/jem.153.2.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horwitz M. A., Silverstein S. C. Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication. J Exp Med. 1981 Feb 1;153(2):398–406. doi: 10.1084/jem.153.2.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Horwitz M. A., Silverstein S. C. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest. 1980 Sep;66(3):441–450. doi: 10.1172/JCI109874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jones T. C., Len L., Hirsch J. G. Assessment in vitro of immunity against Toxoplasma gondii. J Exp Med. 1975 Feb 1;141(2):466–482. doi: 10.1084/jem.141.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jones T., Youmans G. P. The in vitro inhibition of growth of intracellular Listeria monocytogenes by lymphocyte products. Cell Immunol. 1973 Dec;9(3):353–362. doi: 10.1016/0008-8749(73)90050-6. [DOI] [PubMed] [Google Scholar]
  19. Mauel J., Buchmüller Y., Behin R. Studies on the mechanisms of macrophage activation. I. Destruction of intracellular Leishmania enriettii in macrophages activated by cocultivation with stimulated lymphocytes. J Exp Med. 1978 Aug 1;148(2):393–407. doi: 10.1084/jem.148.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meyer R. D., Finegold S. M. Legionnaires' disease. Annu Rev Med. 1980;31:219–232. doi: 10.1146/annurev.me.31.020180.001251. [DOI] [PubMed] [Google Scholar]
  21. Nacy C. A., Meltzer M. S. Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi. J Immunol. 1979 Dec;123(6):2544–2549. [PubMed] [Google Scholar]
  22. Nathan C. F., Terry W. D. Decreased phagocytosis by peritoneal macrophages from BCG-treated mice: induction of the phagocytic defect in normal macrophages with BCG in vitro. Cell Immunol. 1977 Mar 15;29(2):295–311. doi: 10.1016/0008-8749(77)90324-0. [DOI] [PubMed] [Google Scholar]
  23. Nogueira N., Cohn Z. A. Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity. J Exp Med. 1978 Jul 1;148(1):288–300. doi: 10.1084/jem.148.1.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nogueira N., Gordon S., Cohn Z. Trypanosoma cruzi: modification of macrophage function during infection. J Exp Med. 1977 Jul 1;146(1):157–171. doi: 10.1084/jem.146.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Patterson R. J., Youmans G. P. Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun. 1970 Jun;1(6):600–603. doi: 10.1128/iai.1.6.600-603.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Poste G., Kirsh R. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Cancer Res. 1979 Jul;39(7 Pt 1):2582–2590. [PubMed] [Google Scholar]
  27. Rocklin R. E., Winston C. T., David J. R. Activation of human blood monocytes by products of sensitized lymphocytes. J Clin Invest. 1974 Feb;53(2):559–564. doi: 10.1172/JCI107590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ruco L. P., Meltzer M. S. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures. J Immunol. 1977 Sep;119(3):889–896. [PubMed] [Google Scholar]
  29. Salvin S. B., Cheng S. L. Lymphoid Cells in Delayed Hypersensitivity II. In Vitro Phagocytosis and Cellular Immunity. Infect Immun. 1971 Apr;3(4):548–552. doi: 10.1128/iai.3.4.548-552.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Saravolatz L. D., Burch K. H., Fisher E., Madhavan T., Kiani D., Neblett T., Quinn E. L. The compromised host and Legionnaires' disease. Ann Intern Med. 1979 Apr;90(4):533–537. doi: 10.7326/0003-4819-90-4-533. [DOI] [PubMed] [Google Scholar]
  31. Sethi K. K., Pelster B., Suzuki N., Piekarski G., Brandis H. Immunity to Toxoplasma gondii induced in vitro in non-immune mouse macrophages with specifically immune lymphocytes. J Immunol. 1975 Oct;115(4):1151–1158. [PubMed] [Google Scholar]
  32. Shirahata T., Shimizu K., Noda S., Suzuki N. Studies on production of biologically active substance which inhibits the intracellular multiplication of Toxoplasma within mouse macrophages. Z Parasitenkd. 1977 Aug 25;53(1):31–40. doi: 10.1007/BF00383112. [DOI] [PubMed] [Google Scholar]
  33. Simon H. B., Sheagren J. N. Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes. Cell Immunol. 1972 Jun;4(2):163–174. doi: 10.1016/0008-8749(72)90015-9. [DOI] [PubMed] [Google Scholar]
  34. Swenson F. J., Kozel T. R. Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages. Infect Immun. 1978 Sep;21(3):714–720. doi: 10.1128/iai.21.3.714-720.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wong K. H., Schalla W. O., Arko R. J., Bullard J. C., Feeley J. C. Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med. 1979 Apr;90(4):634–638. doi: 10.7326/0003-4819-90-4-634. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES